共 192 条
[1]
McDonagh TA(2022)ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 24 4-131
[2]
Metra M(2019)Contemporary drug treatment of chronic heart failure with reduced ejection fraction: the CHECK-HF Registry JACC Heart Fail 7 13-21
[3]
Adamo M(2019)READY: relative efficacy of LDs in patients with chronic systolic heart failure-a systematic review and network meta-analysis of randomised trials Heart Fail Rev 24 461-472
[4]
Gardner RS(2016)Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction Eur J Heart Fail 18 328-336
[5]
Baumbach A(2016)Cardiac dysfunction, congestion and loop diuretics: their relationship to prognosis in heart failure Cardiovasc Drugs Ther 30 599-609
[6]
Böhm M(2017)Changes in loop diuretic dose and outcome after cardiac resynchronization therapy in patients with heart failure and reduced left ventricular ejection fractions Am J Cardiol 120 267-273
[7]
Brunner-La Rocca HP(2013)EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot) Eur J Heart Fail 15 808-817
[8]
Linssen GC(2014)Lowering furosemide dose in stable chronic heart failure patients with reduced ejection fraction is not accompanied by decompensation: a randomized study Int J Cardiol 177 690-692
[9]
Smeele FJ(2019)The use of diuretics in heart failure with congestion—a position statement from the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail 21 137-155
[10]
van Drimmelen AA(2021)To master heart failure, first master congestion Lancet 398 935-936